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Abstract
Bacteraemia caused by Escherichia coli is a growing problem with a significant mortality. The factors that influence the
acquisition and outcome of these infections are not clear. Here, we have linked detailed genetic data from the whole-genome
sequencing of 162 bacteraemic isolates collected in Scotland, UK, in 2013–2015, with clinical data in order to delineate
bacterial and host factors that influence the acquisition in hospital or the community, outcome and antibiotic resistance. We
identified four major sequence types (STs) in these isolates: ST131, ST69, ST73 and ST95. Nearly 50% of the bacteraemic
isolates had a urinary origin. ST69 was genetically distinct from the other STs, with significantly less sharing of accessory
genes and with a distinct plasmid population. Virulence genes were widespread and diversely distributed between the
dominant STs. ST131 was significantly associated with hospital-associated infections (HAIs), and ST69 with those from the
community. However, there was no association of ST with outcome, although patients with HAI had a higher immediate
mortality compared to those with community-associated infections (CAIs). Genome-wide association studies revealed genes
involved in antibiotic persistence as significantly associated with HAIs and those encoding elements of a type VI secretion
system with CAIs. Antibiotic resistance was common, and there were networks of correlated resistance genes and
phenotypic antibiotic resistance. This study has revealed the complex interactions between the genotype of E. coli and its
ability to cause bacteraemia, and some of the determinants influencing hospital or community acquisition. In part, these are
shaped by antibiotic usage, but strain-specific factors are also important.
DATA SUMMARY
Illumina sequences have been deposited in the European
Nucleotide Archive under project PRJEB12513.
INTRODUCTION
The Gram-negative bacterium Escherichia coli is a common
gut commensal in man, as well as an important cause of a
range of intestinal and extra-intestinal infections [1, 2]. It is
the leading cause of bloodstream infection across Europe
and the USA [3, 4], with a high attributable mortality of
between 10–30% that rises with age [5–7]. Rates of E. coli
bacteraemia have increased dramatically over the last 10–
20 years, rising 25.6% between 2012/3 and 2016/7 in Eng-
land and Wales [8], and 46% between 1992 and 2006 in
Denmark [5], with similar increases within the USA [3].
Across Europe, isolates of E. coli from blood collected by the
European Antimicrobial Resistance Surveillance System
increased by 60% from 2002 to 2008 [4]. About half these
bacteraemias are hospital or healthcare associated, with
reported percentages of just over 50% in Scotland in 2016
[9, 10] and in England in 2012/3 [11]. Thus, community-
associated infections (CAIs) are also a significant cause of
bacteraemias.
The mechanisms underlying these increases in incidence
worldwide remain obscure. Data from Europe show that the
increase has been more marked in antibiotic-resistant
organisms, many of which are multidrug resistant [4]. A
more focussed study in England also found an increasing
incidence of antibiotic-resistant strains [12]. Because of
the rise in incidence of E. coli bacteraemias, enhanced
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surveillance programs have been instituted in both England
and Scotland. Preliminary data from the surveillance in
England has shown about half of all patients had previous
healthcare exposure in the month prior to the bacteraemia
[11]. The source of bacteria was estimated to be the urogeni-
tal tract in about 50% of cases. The Scottish data also
showed a urinary source in about half of the bacteraemic
cases [9].
A number of studies have analysed the genetic make-up of
E. coli lineages isolated from the urinary tract and/or bac-
teraemias [2, 13–17]. These have characterized the domi-
nant multilocus sequence types (MLSTs) associated with
these infections: sequence types (STs) ST73, ST131, ST95
and ST69 are the most prevalent in both the UK and the
USA. ST131 has come to prominence in the last few deca-
des as a widely distributed strain that typically has a
multidrug-resistant phenotype [18, 19]. A recent study
estimated that ST131 underwent rapid expansion in about
1995 [20]. However, this expansion stabilized quite rapidly,
with a new equilibrium established with other E. coli STs.
Antibiotic resistance is not the only factor involved in the
success of E. coli strains, since ST73 is the most abundant
phenotype found in some studies and is typically antibiotic
susceptible. Although whole-genome sequencing has been
performed on large collections of clinical isolates, these
have lacked detailed clinical data on the source patients
and, thus, the clinical factors involved in selection of dif-
ferent bacterial genes that might be associated with the
observed increase in rates of bacteraemia and their origin
remain unknown.
The ability to link full clinical data with whole-genome
sequences of causative microbes greatly increases the ability
to identify key pathogen factors involved in acquisition and
subsequent development of disease. Here, we have taken
advantage of the rich clinical data provided by enhanced
surveillance of E. coli bacteraemias within Scotland to link
this with whole-genome sequencing of the causative strains.
Our aim was to explore potential factors associated with the
microbe and the host that lead to bacteraemia, and in
particular to examine the determinants of CAI versus hospi-
tal-associated infection (HAI). A total of 162 bacteraemic
E. coli isolates from 2013 and 2015 were fully sequenced and
analysed in tandem with the clinical data available on each
source patient that was recorded as part of an enhanced sur-
veillance program. The results presented here allowed us to
examine in depth the population structure of E. coli strains
causing bacteraemia, and to relate this to the clinical risk
factors, antibiotic sensitivities and course of infection. We
identified genes important in HAIs versus CAIs by genome-
wide association study, which revealed that acquisition of
antibiotic tolerance is an important factor in bacterial fitness
in healthcare environments. We observed differing viru-
lence determinants between different strains, and evidence
of co-selection of multiple antibiotic-resistance genes
(ABRs).
METHODS
Collection of E. coli isolates and whole-genome
sequencing
A total of 162 blood culture E. coli isolates were selected ret-
rospectively from the microbiology laboratories of the
Queen Elizabeth University Hospital, Glasgow, Scotland,
UK, and Dumfries Royal Infirmary, Dumfries, Scotland,
UK. For the Queen Elizabeth Hospital, all non-duplicate
isolates in the last quarter of 2013 (97) and from a 6week
period in the last quarter of 2015 (41) were taken. From
Dumfries, all non-duplicate isolates from the last quarter of
2013 were collected (24). The total numbers of E. coli bac-
teraemic isolates during these periods were 428 in 2013 and
576 in 2015 from Glasgow, and 95 in Dumfries for 2013.
Genomic DNA was extracted at each site using QIAmp
(Qiagen) and index-tagged paired-end Illumina sequencing
libraries were prepared. Sequencing was performed at the
Welcome Trust Sanger Centre (Hinxton, UK) using the 96-
plex Illumina HiSeq 2500 platform to generate 2200 bp
paired-end reads. These raw Illumina sequences have been
deposited in the European Nucleotide Archive under project
PRJEB12513.
Clinical data for linkage analysis
The clinical data for the Scottish isolates had been collected
from blood specimens with patient outcome (e.g. died in
hospital or discharged) along with date of death/discharge,
IMPACT STATEMENT
Blood stream invasion with the bacterium Escherichia coli
is increasing across the UK and carries a poor prognosis.
About half of these infections are acquired in healthcare
settings, with the rest arising from the community. The
microbial and host factors that determine the acquisition
and outcome of these infections are not known. To
uncover some of these factors, we have undertaken
whole-genome sequencing of bloodstream isolates of
E. coli from patients and linked these to their clinical
data. We identified the major genetic families of E. coli
causing bloodstream infection in Scotland. Genetic analy-
sis showed that genes conferring an ability to microbes
to survive at low growth rates in the presence of antibiot-
ics were important in hospital-associated infections
(HAIs). Genes encoding a mechanism to compete with
other microbes were important in community-associated
infections (CAIs). Outcome was worse in HAI and was
associated with urinary catheter use. Genes encoding
resistance to antibiotics used extensively in hospitals
clustered together in strains from HAIs, suggesting co-
inheritance of multiple resistance genes in these strains.
These results show how antibiotic use is driving the evo-
lution of strains causing bloodstream infection in hospi-
tals; factors responsible for CAI are less clear.
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catheter association during hospital admission, age, sex,
infection type (e.g. urosepsis, bone, skin, respiratory tract or
gastrointestinal) and mode of acquisition whether it was a
HAI or a CAI. Bacteria isolated from samples taken greater
than 48 h after admission to hospital were classified as HAI
and those within 48 h of admission to hospital were classed
as CAI. Bacterial minimum inhibitory concentration (MIC)
and antibiotic-sensitivity data for each isolate were also col-
lected. Multilocus sequence typing analysis of all the isolates
was carried out with SRST2 [21], using maximum number
of mismatches per read for MLST allele calling as 10.
Phylogenetic analysis and variant detection
The raw Illumina reads were mapped to the E. coli
reference genome EC958 (strain ST131, accession no.
NZ_HG941718.1) using SAMtools mpileup [22] and were
called for single nucleotide polymorphisms (SNPs) through
VarScan [23] (read depth 2, variant allele frequency
0.08 and P value 0.005). Mobile genetic elements were
masked and recombination filtration was performed using
Gubbins [24]. Maximum likelihood (ML) trees were
inferred using RAxML [25] with the generalized time-
reversible (GTR) model and a gamma distribution to model
site-specific rate variation. One hundred bootstraps were
conducted for the support of the SNP-based ML
phylogenetic tree.
Pangenome analysis
De novo assembly of the Illumina reads and the annotation
of the coding sequence regions were conducted using the
Sanger pipeline [26]. Core and accessory genes were identi-
fied using Roary [27] with BLASTP identity 95% and per-
centage of isolates to be in the core genome taken as 99%.
The accessory gene (>5 and <99% isolates) accumulation
curves were generated separately for each of the dominant
STs using R. Non-metric multidimensional scaling (NMDS)
was performed using the vegan package in R (http://cran.r-
project.org/web/packages/vegan/index.html). The variation
of core gene and accessory gene content was performed
using pairwise distances. For each pair of isolates, we calcu-
lated their cophenetic distance from the core gene phyloge-
netic tree and the Jaccard distance based on presence or
absence of accessory genes. These two distances were plot-
ted against each other to compare the diversity of core and
accessory genes in Fig. 2(c). Plasmid incompatibility types
and subtypes were identified using PlasmidFinder [28].
Pathway analysis
Genes were extracted from all the isolates using an in-house
python script and linked to KEGG (Kyoto Encyclopedia of
Genes and Genomes) orthologue or KO groups using DAVID
[29]. The fold enrichment for each pathway was evaluated
with reference to E. coli K-12 genome.
Virulence genes
Virulence genes were identified using the VirulenceFinder
database [30] of SRST2 with percentage of coverage cut-off
for calling a gene 90, keeping default values for all other
parameters. We found 437 virulence genes in our 162 iso-
lates. A Kruskal–Wallis non-parametric test (with Bonfer-
roni correction adjusted P values for multiple testing) was
performed in R using the stats package.
Survival analysis
Survival was analysed by the Kaplan-Meier method and
comparisons between subgroups were examined by the log
rank test using the survival package in R. Cox proportional
hazards analysis was carried out to identify the predictors
for 6months mortality that were independent (univariate
analysis) or dependent of age and gender (multivariate
analysis).
Genome-wide association study
Pangenome-wide association study was carried out on pan-
genome genes extracted from all the isolates. Using Scoary
[31], the significant genes were identified that were different
between the HAI versus CAI groups of isolates. A Kruskal–
Wallis significance test with Bonferroni correction was also
conducted to reconfirm the significance. The Manhattan
plot has genes along the x-axis in no particular order and
the y-axis gives the negative logarithm with base 10 of the
significant P values.
ABRs and network analysis
ABRs were detected using ARIBA [32] using the CARD data-
base. Altogether 52 ABRs were identified (see the Supple-
mentary Material available in the online version of this
article). The correlation networks of ABRs gene presence/
absence matrix and clinical susceptibility (R/S) matrices
were constructed using Pearson’s correlation and the Hmisc
v4.0–2 package in R. The cut-off edge weight value was set
at a correlation of >0.5 for the network plot.
RESULTS
Study design
We selected isolates of E. coli from blood cultures taken
from patients within the Greater Glasgow and Clyde Health
Board over a 2month period in 2013 and in 2015. We also
collected similar isolates from patients within Dumfries and
Galloway in 2013. After removal of potential duplicates,
samples that failed to grow and those that failed to provide
full genomic sequences, we were left with a total of 162 iso-
lates that were fully analysed as below.
Population structure of isolates
De novo genome assembly produced sequences ranging in
length from 4.6 to 5.1 Mbp genomes. A total of 20 855 genes
were identified from these assemblies, of which 13% (2804
genes) were conserved in more than 99% of genomes. These
core genes were used to generate a 2.68 Mbp base pair align-
ment, which was used to construct a phylogenetic clustering
analysis (Fig. 1a). The MLST scheme identified four domi-
nant STs found in more than 10 isolates within our 162 iso-
lates: ST131 (39, 24%), ST69 (26, 16%), ST73 (20, 12%)
and ST95 (15, 9%). Other strains accounted for 38% of the
Goswami et al., Microbial Genomics 2018;4
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isolates. The ML phylogenetic analysis, with 100% boot-
strap support, corresponded very well with the MLST iden-
tified strain types. The tree was rooted on the longest
branch, separating the ST69 strains (phylogroup D) from
the other strains ST131, ST73 and ST95, which belong to
the phylogroup B2. The source of the bacteraemic isolates
was identified by case note review for 144 of the isolates
(Fig. 1b). A urinary origin was the commonest source
(49%), followed by abdominal (20%) and respiratory (9%)
origins.
Sub-analysis of the ST131 isolates into the clades described
by Price et al. [33] and Petty et al. [34] showed that the
majority of the ST131 isolates were in clade C (29/39; 74%),
characterized by being of serotype O25H4 and possessing
the fimh30 allele (see Fig. S1). Further subdivision of the C
clade was made using clade-specific SNPs as described by
Ben Zakour et al. [35]. Five isolates were sensitive to cipro-
floxacin (C clade). Of the ciprofloxacin-resistant strains, 5
were in clade C1 and 19 in clade C2. Possession of the
extended spectrum b-lactamase CTMX-15 has been
described as a marker of clade C2. We found 10/19 clade 2
isolates had this gene; in addition, 1 had the gene for
CTXM-9. C1 isolates lacked CTXM-15, but one had the
CTXM-9 gene. CTXM-15 has, thus, been acquired/lost
repeatedly within the C2 clade as noted also by Kallonen
et al. [20]. One clade A isolate had also acquired the
CTXM-15 gene.
Accessory gene analysis
We hypothesized that the accessory gene content of the iso-
lates would contain genes important in establishing blood
stream infection that were common across all the ST types.
Within the 162 isolates, 69% (n=14 328) of the pangenome
was identified within the dominant strain types ST131,
ST73, ST95 and ST69. We identified 5757 accessory genes
that are present in (5 and <99%) our 162 genomes. Most
of the accessory genes were rare, and only 22% have been
identified functionally. To measure the size of the accessory
genome, we determined the numbers of new genes identi-
fied with increasing numbers of genomes sampled for each
of the dominant ST types (Fig. 2a). This showed that for all
STs, there was a steady rise in the number of new genes
identified with increasing sampling. As noted before for
E. coli, this did not reach a plateau for any of the STs. The
accumulation curves fitted a power law as given by Heaps’
law, as described by Tettelin et al. [36]. The derived con-
stant a was less than 1 for all ST, indicating an open pange-
nome. However, as Fig. 2(a) shows, the accumulation curve
for ST69 rises more rapidly than the other STs. This is
reflected in the derived a constants, which is lowest for the
ST69 isolates. Comparing ST69 to the largest group, ST131,
the difference in the distributions was significant (two sam-
ple Kolgomov Smirnoff test, P=0.0071). Overall measures of
accessory gene diversity showed all STs were highly diverse,
although ST131 and ST69 were marginally more diverse
than the other two STs (see Fig. S2).
Next, we assessed whether the accessory gene composition
reflected the ST or grouped the isolates in another fashion.
Similarity between the accessory gene content of each isolate
was analysed using NMDS based on the Jaccard distance of
accessory genes between each isolate (Fig. 2b). This showed
Fig. 1. (a) ML SNP core gene phylogeny of the E. coli isolates. The STs
were identified using the MLST scheme. STs with fewer than 10 iso-
lates are clustered in the category ‘others’. The key indicates phy-
logroups and whether the isolates were community associated (CA) or
hospital associated (HA). (b) Source of bacteraemia as percentages of
total isolates. Line, indwelling vascular device; SST, skin and soft
tissue.
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that isolates grouped according to ST rather than any other
parameter. However, there were significant differences in
which STs were associated with HAI or CAIs (multinomial
goodness of fit test, P<0.05, exact binomial probability).
ST131 was highly associated with HAI (82% of isolates,
exact binomial compared to overall rate of HAI of 62%,
P<0.05) and ST69 significantly associated with CAI (62% of
isolates, exact binomial compared to overall rate of CAI of
38%, P<0.05)
The variation in the accessory gene pool was further
assessed by comparing the core genome divergence and
accessory gene content in pairwise comparisons (Fig. 2c).
Comparison of isolates with other members of the same ST
showed little difference in their accessory gene content, clus-
tering towards the origin of the plot (blue dots). Pairwise
comparison between all isolates of different ST groups other
than ST69 are shown in red, and cluster quite separately
from the intra-ST pairwise comparisons. This discontinuity
reflects a distinct clonal structure to the population, since
higher rates of recombination between STs has been shown
to generate a more homogeneous distribution [37]. Com-
parison of ST69 with all other isolates shows a more
extreme clustering in the upper right of the plot (green),
highlighting the divergence of ST69 from the other STs,
with a significantly different accessory gene content that
does not appear to be undergoing exchange from the other
STs. This does not reflect any difference between the recom-
bination rates in ST69 compared to the other STs; recombi-
nation rates between the different STs were very similar (see
Fig. S3). As a comparison, we compared core gene diver-
gence and accessory gene content between ST73 and ST95,
which are more closely related in core gene content (purple
dots). Accessory gene content was more divergent between
these groups than for the intra-strain comparison, but not
so extreme as between ST69 and the other STs.
A proportion of accessory genes will be present on different
plasmids between the isolates. Although from the short
reads provided by Illumina sequencing we were unable to
reconstruct plasmids, we identified plasmid profiles within
the isolates based on the presence of specific replicon genes
that places them in different incompatibility (Inc) groups
(Fig. S4). Ten plasmid Inc groups were identified across all
the strains. The broad range IncQ plasmids were predomi-
nantly found in isolates of ST69 (42% of the isolates, Fig.
S4); the differences between the groups were significant by
G test of independence (P<0.001 with Williams correction),
with significant increases in the percentage of IncQ plas-
mids in ST69 compared to ST131 and ST73 (G test false dis-
covery rate corrected P values of 0.002 and 0.01,
respectively). Other plasmids without recognized replicon
genes may also be present in these strains.
We compared the pathway designations of the core and
accessory genomes of the different isolates (Fig. 3). Com-
pared to the E. coli reference strain K12, the core genome
showed modest but significant enrichment principally of
metabolic pathways (Fig. 3a). The accessory genome had
over-representation of different pathways (Fig. 3b). These
included phenylalanine metabolism, products of which have
been implicated in bacterial pathogenesis [38]. We also
determined which genes were common in the accessory
genome of the different isolates but not at the 99% thresh-
old of the core genome. A total of 495 genes were identified
as shared between 80% of the commonest isolates ST131,
ST69 and ST73. Pathway analysis of these genes did not
reveal any significant common pathways.
Virulence genes
We used the Virulence Factor Database [39] to determine
the different virulence genes within the different E. coli
strains. A total of 363 different virulence genes were
Fig. 2. (a) Accessory gene accumulation curves for the dominant STs with respect to the number of genomes compared. At each
value x of the number of genomes compared, a random sample n of genomes was compared in n!/(n x)!x! ways. The solid line shows
the median value at each value of x; the shaded area contains the interquartile values. (b) NMDS plots of the different dominant STs
based on their shared accessory gene content. Community or hospital origin are as indicated. Dotted lines are 95% confidence limits
of values around the centroid for each ST. (c) Comparison of core and accessory genomes of different STs. Each circle is the core
genome similarity as cophenetic distance plotted against accessory gene similarity as Jaccard distance for each possible paired com-
parison within the different groups as indicated in the key.
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detected. In keeping with the predominantly urinary origin
of about 50% of the isolates, genes previously identified as
important in urinary pathogenic E. coli were highly preva-
lent. Genes encoding siderophores showed considerable var-
iation between the different dominant ST strains (Fig. 4).
Genes encoding enterobactin, haemin, yersinobactin and
the metal transporter SitA were found in virtually all of the
dominant STs. However, genes for salmochelin and colibac-
tin were almost exclusively present in ST95 and ST73
(Fig. 4). Fig. S5 (a–d) shows the distribution of individual
siderophore genes between the STs. Genes of the salmoche-
lin operon (iroBCDEN) were present together in the salmo-
chelin-positive strains. Likewise, genes of the colibactin
operon were also found within ST95 and ST73. Two differ-
ent alleles of the iutA gene that is involved in aerobactin
synthesis were distributed differentially between the differ-
ent STs; the allele VFG012518 has been found in plasmids
isolated from avian pathogenic E. coli strains, suggesting
possible transmission of plasmids or elements of these plas-
mids between humans and farmed poultry [40].
Virulence genes that showed a significant difference
between the dominant STs are shown in Figs S5 and S6. The
diversity of virulence gene content between the different
STs is very clear. Some of these genes were only found
within one ST. Numerous adhesins that are known to be
important in the pathogenesis of urinary infection were
present in these isolates, and some significant differences
were detected. Some of the divergence is associated with dif-
ferent alleles of adhesion genes, such as papG, which is the
terminal component of P type pili that is key in mediating
attachment of bacteria to receptors within the kidney and
initiating pyelonephritis. This allele (vfg000890) is a class II
papG that is known to be important in attachment of E. coli
to cells in the upper urinary tract and in the development of
sepsis [41, 42]. However, some of the ST73 isolates were
unique in possessing genes encoding components of the S
Fig. 3. KEGG pathway analysis of (a) core and (b) accessory genes of the different isolates. Comparison was made to the KEGG assig-
nation of genes with the E. coli reference strain K12. Bars show the genes significantly associated within each KEGG group as a per-
centage of the total number of the core or accessory genes with a KEGG pathway assignation. Fold enrichment of the different groups
is as indicated in the colour key. Superimposed numbers are the number of genes assigned within the indicated KEGG pathway.
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and FIC pili [43], which were not seen in any of the other
isolates. There were significant differences in the presence
of members of the serine protease autotransporters of
Enterobacteriacae (SPATE) family [44]. A previous study of
ST131 found the SPATE family gene espC in 99% of ST131
isolates [20]; however, we only found one of our isolates
contained this gene, which was an ST131. ST69 strains con-
tained many genes that are part of a second type III secre-
tion system (ETT2) [45] previously described in strains of
enterohaemorrhagic and enteroadhesive E. coli, which we
found intact in a complete operon. Finally, members of
strains ST73 and ST131 possessed genes of the haemolysin
operon, a toxin important in the pathogenesis of urinary
E. coli infections [46].
Outcome and risk factors for death
To begin to dissect the contribution of this diverse genomic
repertoire to disease, we compared the outcome of patients
infected with the different dominant ST types (Fig. 5a). The
Kaplan–Meir survival curves show little difference between
the different STs in mortality; ST69 shows a slower rate but
multiple comparisons did not reveal statistically significant
differences (Cox proportional hazards model with correc-
tion for multiple testing). Mortality between HAI and CAI
showed a significant difference (Fig. 5b). HAIs showed a
Fig. 4. Distribution of siderophores within the major STs. (a) Percentage of each major ST containing the genes for the indicated side-
rophore systems. (b–d) Individual occurrences of each indicated siderophore gene within the different STs. Genes are scored as pres-
ent (1) or absent (0), with each circle representing a single isolate; symbols are dodged to aid in viewing. Calculated q values are
shown in each graph header; values <10 6 are assigned as 0.
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worse outcome; the curves separated markedly in the first
90 days after the E. coli was isolated and then became paral-
lel. We also tested whether presence of a urinary catheter
influenced outcome (Fig. 5c). Early mortality was signifi-
cantly more marked in patients who had a urinary catheter
at some point in their hospital stay. We performed
univariate and multivariate analysis of 6month mortality in
this group of bacteraemic patients with a number of clinical
factors (Table 1). Age, presence of a urinary catheter and a
respiratory source were all significant risk factors for
6month mortality in a univariate analysis. Presence of a uri-
nary catheter and respiratory source remained significant in
a multivariate analysis.
Determinants of HAI versus CAI
Sixty-two per cent of all the bacteraemic isolates were from
HAI. We wished to discover the determinants of HAI versus
CAI using the whole-genome sequence data. To analyse the
determinants within isolates that favour healthcare-associ-
ated or community-acquired bacteraemia, we performed a
genome-wide association study to identify those genes pref-
erentially present in the two different groups (Figs 6 and
S7). We used the software programme Scoary [31], which
scores the pangenome of isolates associated with phenotypic
characteristics while accounting for population stratifica-
tion. This correction is important, as spurious associations
of genes with phenotypic characteristics may arise because
of the strong association of some genes with different STs in
E. coli.
In the healthcare-associated bacteraemic isolates, we did not
find any significant association with genes mediating antibi-
otic resistance, but there was a significant association with
the chpB/chpS genes encoding a chromosomal toxin/anti-
toxin pair. ChpB is a toxin of a type II toxin/antitoxin
module that is an endoribonuclease, inhibiting protein
translation and inducing bacterial stasis [47, 48]. Such chro-
mosomal toxin/antitoxin modules are increasingly recog-
nized as crucial in the phenomenon of bacterial persistence
[49]. These are cells that enter into a dormant non-growing
state on exposure to antibiotics or other adverse conditions
that allows them to survive until such environmental stress
is relieved. Another gene found significantly more fre-
quently in isolates from HAIs is BglH (YieC), which encodes
an outer-membrane carbohydrate-specific porin [50]. In
isolates from CAIs, a number of genes associated with a
type VI secretion system were identified: an Rhs/Vgr-family
protein (gp_319), and a PAAR-repeat-containing protein
(gp_3584). Additionally, the gene higB-1 was more common
in the community-acquired isolates; this encodes a putative
mRNA interferase as part of a toxin/antitoxin pair [51].
Resistance to antimicrobials
In the collection, 98 resistance genes were identified; their
distribution is shown in Fig. S8. Mutations conferring cipro-
floxacin resistance were also present. There were signifi-
cantly higher numbers of ABRs in ST131 and ST69
compared to the other STs (Fig. 7a). However, there was no
difference between the ABR counts between isolates from
HAI and CAI (Fig. 7b). We compared phenotypic resistance
to five key antibiotics between the four main STs: 3rd gener-
ation cephalosporins, ciprofloxacin, co-amoxiclav, gentami-
cin and trimethoprim (Fig. 7c). This revealed significant
differences between the main STs (overall G test,
Fig. 5. Kaplan–Meir survival curves of the patients within the study
stratified according to (a) ST, (b) CAI or HAI and (c) presence or
absence of urinary catheter. P values show the significance of the
differences between the outcomes using the Cox proportional hazards
model.
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P=1.8410 11); differences between all possible pairs were
also significant (G test pairwise nominal test for indepen-
dence with false discovery rate correction, P values all
<0.05). ST131 was notable for significant antibiotic resis-
tance in all of these classes, as has been noted elsewhere
[19]. In particular, some ST131 strains contained extended
spectrum b-lactamases of the CTX-M class, which mediate
resistance to 3rd generation cephalosporins. The predomi-
nantly community-associated ST69 showed high levels of
phenotypic resistance to co-amoxiclav (31% of isolates) as
did ST131 (51% of isolates). Both ST131 and ST69 showed
a high percentage of resistance to trimethoprim (69% of
isolates for both STs).
We wished to determine whether there were significant
correlations between phenotypic resistance to certain antibi-
otics and the presence of known ABRs. We hypothesized
that increased levels of antibiotic use as found for HAI
might result in selection for multiply resistant strains. More-
over, the common organization of ABRs within integrons
[52] and within plasmids [53] could result in the co-selec-
tion of many different ABRs as a group. We tested this
hypothesis by calculating the Pearson correlation coefficient
between presence and absence of ABRs within strains and
antibiotic susceptibility, coded as sensitive or resistance. The
correlation matrices were visualized with a network plot
(Fig. 8). Nodes for ABRs are shown in green/purple, and
phenotypic resistance in red. Linking edges show the degree
of correlation; the higher the degree of correlation, the
shorter the edge. Only correlations with a value >0.5 are
shown. The plot shows a number of key relationships.
Firstly, there is a marked strong correlation between antibi-
otic resistance to a group of antibiotics whose use is largely
confined to hospital use, such as gentamicin, tobramycin,
aztreonam, ertapenem and 3rd generation cephalosporins
(all clustered closely to the left of the figure). A number of
ABRs are associated with these phenotypic resistances.
These include extended spectrum b-lactamases of the
CTXM class as well as b-lactamases of the OXA class that
are associated with resistance to co-amoxiclav [54]. Amino-
glycoside-resistance genes are also contained within this
group: aac(3¢)II encodes an aminoglycoside N-acetyltrans-
ferase that mediates resistance to gentamicin and tobramy-
cin, while aac(6)Ib encodes a protein that mediates
resistance to gentamicin and other aminoglycosides [55].
On the right of the network is a looser cluster of ABRs and
phenotypic resistances. These are centred around amoxicil-
lin and trimethoprim, both antibiotics with extensive com-
munity use. Trimethoprim resistance is linked to the dfrA1
gene, a dihydrofolate reductase allele that is not inhibited by
trimethoprim. However, there is close correlation also with
the streptomycin/spectinomycin resistance gene aadA1,
genes within an erythromycin-resistance operon (mrx and
mphA), and sul1, a sulphonamide-resistance determinant.
This would seem to be an example of co-selection, as these
genes are commonly found linked as part of an integron
[56]. These alleles were extremely closely linked; of 51 iso-
lates with the dfrA1 trimethoprim-resistance gene, 47 also
contained the aadA1 gene. Similar considerations apply to
the linkage between the b-lactamase of the TEM class that
mediates amoxicillin resistance, and aph3Ib and aph6Id,
which mediate kanamycin/streptomycin resistance, and
sul2, which mediates sulphonamide resistance. sul2, aph3Ib
and aph6Id are commonly genetically linked on DNA frag-
ments found in plasmids, integrative elements and chromo-
somal islands [55].
A separate sub-network links amikacin resistance to the
genes encoding transcriptional regulator leuO and catB3,
which mediates chloramphenicol resistance. LeuO has been
shown to influence expression of a number of operons
involved in drug resistance [57]. The linkage between catB3
and amikacin resistance is not clear.
Table 1. Univariate and multivariate analysis for predictors of 6months mortality calculated on 162 isolates
P values (P val) and confidence intervals (CI) are shown. P values less than 0.05 are shown in bold.
Univariate analysis Multivariate analysis
Variable Odds ratio P val 95%CI Odds ratio P val 95%CI
Gender – female (ref: male) 0.91 0.8369 0.37–2.23
Age>65 (years)(ref: 65 (years)) 3.66 P=0.0384 1.07–12.48
Hospital (ref: community) 1.73 0.2627 0.66–4.49 1.62 0.3411 0.60–4.34
Urinary catheter (ref: no catheter) 4.83 P=0.0005 1.97–11.83 6.22 P=0.001 2.09–18.48
Diagnosis (ref: gastrointestinal)
Urosepsis 1.83 0.4371 0.40–8.33 1.34 0.7121 0.27–6.45
Respiratory 7.03 P=0.0243 1.29–38.43 5.55 P<0.05 0.97–31.499
Others 1.36 0.7210 0.25–7.44 1.91 0.4873 0.31–11.95
Strain types (ref: 0)
ST131 0.78 0.6531 0.26–2.33
ST69 0.57 0.4451 0.13–2.44
ST73 1.30 0.6735 0.38–4.44
ST95 1.10 0.8982 0.26–4.47
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DISCUSSION
We have analysed whole-genome sequences of E. coli iso-
lated from blood cultures of patients in Scotland in 2013
and 2015, and linked them to clinical data on the same
patients. This has allowed us to explore the relationships
between genes within these isolates and the origins and clin-
ical course of these infections, as well as detailed informa-
tion on the range of strains producing these infections and
their sensitivity to antibiotics. The four most prevalent STs
found in our study – ST131, ST69, ST73 and ST95 – are
similar to those in reports of isolates from elsewhere in the
UK, Ireland and the USA [2, 13–17, 20]. About half of our
isolates had a urinary origin and this was reflected in the
content of virulence genes, which contained many genes
known to be involved in the pathogenesis of urinary infec-
tion and pyelonephritis. Most of the isolates were from the
known virulent phylogroups B2 and D [58].
A recent study of isolates from the UK showed the appear-
ance of ST131 and ST69 from about 2002 [20]. ST131 was
the commonest ST in our study and was more prevalent in
hospital-acquired bacteraemias, as found in other studies
[19]. ST73 was only the third most prevalent ST (12%) of
our isolates, compared to a recent study of bacteraemic iso-
lates in England from 2001 to 2011 in which it was the most
common isolate [20]. ST69 was the second commonest ST
in our isolates and shows some significant differences from
the other STs causing bacteraemias. ST69 was more com-
mon in CAI and diverged the most from the other domi-
nant STs in its core gene content as well as its accessory
genome (Fig. 2). The marked divergence of ST69 accessory
genome from the accessory genomes of the other dominant
STs suggests very little recombination is occurring with
these other STs. We also found a higher content of plasmids
with IncQ replicons within ST69 compared to the other
STs. Taken together, these differences highlight that ST69 is
significantly distinct from the other STs and would appear
to occupy a rather distinct ecological niche compared to the
other STs.
Virulence determinants were widely distributed within the
isolates. However, no common pattern of such determinants
Fig. 6. Manhattan plot of association of genes with CAI or HAI detected by a genome-wide association study. Association of genes with
phenotype was determined by multiple Kruskal–Wallis tests. Uncorrected P values are shown with the Bonferroni corrected P value
for significance threshold indicated by the red horizontal line. Genes more highly represented in HAI are shown in green and those
more highly represented in CAIs are in red. Individual distributions of Bonferroni corrected significant associations are shown in
Fig. S7.
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was found. Rather, there are multiple different combina-
tions of such factors within bacteraemic isolates that segre-
gate between STs rather than any other factor. Although
some determinants were found in several of the dominant
STs, some were only present in one ST. This suggests that
these factors were either acquired subsequent to the diver-
gence of the different STs or lost in those that no longer
possess the factor. It is difficult to determine which of these
alternatives have given rise to the observed lineages. Estab-
lishing the ancestral history of E. coli is problematic because
of the high degree of recombination and horizontal gene
transfer [59]. Loss of gene function can allow a pathogen to
be better adapted to a new niche [60]. ST69 was unusual in
possessing an intact second type III secretion system
(ETT2) [45] previously described in strains of enterohae-
morrhagic and enteroadhesive E. coli, which we found intact
in a complete operon. What contribution this might make
to the pathogenesis of bacteraemia produced by this ST is
not clear. That most other E. coli strains contain degenerate
versions of the ETT2 [45] suggests it is ancestral in ST69.
Genes that were present in isolates of one or two STs were
more likely to have been acquired during evolution of the
various strains.
Analysis of the accessory gene content of the different iso-
lates gave a similar result as seen with analysis of the viru-
lence genes. We had hypothesized that there might be a
‘common’ set of accessory genes present in our isolates that
would be important in producing bacteraemia. This was not
the case; no particular functional class of genes were found
in the accessory genome. The accessory gene pool of E. coli
is open, essentially unbounded. This strongly suggests that
different STs must exist in different ecological niches, as
they do not share significant accessory genome content. The
origin of these pathogenic strains is most likely from strains
carried within the human gut that then colonize the urinary
tract and from there invade the bloodstream. The mainte-
nance of distinct accessory genomes between the different
STs could be explained by a number of different mecha-
nisms. Colonization of the human gut from another source
may be in evolutionary terms a too recent event for signifi-
cant gene transfer between the different STs to have
occurred. Alternatively, these pathogenic strains may be
only transiently present in the gut microbiota and are
replaced from time to time from another source. Studies of
faecal carriage of extended spectrum b-lactamase-producing
E. coli in patients who had a urinary infection with these
pathogens show that they are cleared from the gut over a
period of a few years [61]. Whether the same holds for non-
extended spectrum b-lactamase producing STs is not clear.
Hospitals might provide an environmental source for rein-
fection of patients, but the origin of community-acquired
E. coli infections is not clear.
We used the whole genome sequences of the bacteraemic
isolates to identify genetic determinants that are associ-
ated with CAI versus HAI. Chromosomal genes encoding
the toxin/antitoxin pair chpB/chpS were strongly
Fig. 7. ABRs and phenotypes within the isolates. (a) Distribution of
ABRs within the different STs. Each circle is the value of single isolate;
boxes show the interquartile range and the horizontal line the median.
* indicates a significant difference between ST131 and others, with
P value as shown. (b) Distribution of ABRs between isolates from com-
munity or hospital sources. Symbols as in (a). There was no significant
difference between the groups. (c) Percentage of dominant STs having
phenotypic resistance to the indicated antibiotics.
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associated with HAIs. Toxin/antitoxin pairs were origin-
ally described in plasmids, where they act as ‘addiction
mechanisms’ for plasmid maintenance. Continued expres-
sion of the labile antitoxin is required to ensure the more
stable toxin is neutralized. Thus, plasmid loss results in
unfettered expression of the more stable toxin and death
of the cell, ensuring a strong selection pressure for plas-
mid maintenance. A number of chromosomal toxin/anti-
toxin pairs have also now been described. Such toxin/
antitoxins are important in mediating the phenomenon of
bacterial persistence, survival in the face of adverse envi-
ronmental conditions such as antibiotic exposure [47, 62].
Stress results in protease destruction of the antitoxin mol-
ecule, resulting in unchecked toxin activity, which produ-
ces growth inhibition. When the stress is relieved, the
bacteria recover and can resume their normal growth.
This is not antibiotic resistance, but importantly has been
found to be closely associated with the onset of true anti-
biotic resistance in laboratory experiments [63]. We spec-
ulate that the association of genes conferring antibiotic
tolerance in HAI reflects the general burden of antibiotic
use in this setting. Selection of these genes then will facil-
itate the subsequent generation and selection of ABRs in
these isolates. Community-acquired strains showed an
increase in genes encoding components of the type 6
secretory systems present in E. coli. Studies have shown
that this system is a potent mediator of inter-species
killing that allows the organism to compete more effec-
tively with other bacteria to establish colonization [64].
This may be important to allow strains such as ST69 that
are more frequently the cause of CAIs to establish coloni-
zation within the gut and/or urinary tract. Together with
the data showing the genetic divergence of ST69 from the
other STs that cause bacteraemias, this supports the view
that ST69 occupies a distinct ecological niche and has
evolved adaptations favouring its survival within the com-
munity and the ability to cause bacteraemia. We hypothe-
size that type VI secretion by ST69 may be an important
factor allowing this successful adaptation and could
potentially be exploited therapeutically.
Antibiotic resistance was highly prevalent in the isolates
examined here. Our network analysis of resistance genes
and phenotypic resistance of isolates revealed two main
clusters. There was a strongly correlated cluster of genes
conferring phenotypic resistance to typical ‘hospital’ anti-
biotics, such as third-generation cephalosporins, amino-
glycosides and b-lactamase-resistant penicillins. This is
strong evidence that within this setting, use of these anti-
biotics is generating cross-resistance to other unrelated
antibiotics, most likely through selection of plasmids con-
taining multiple antibiotic-resistance determinants. This
phenomenon also is seen with the predominantly ‘com-
munity’ utilized antibiotics trimethoprim and amoxicillin.
Fig. 8. Network analysis of ABRs and phenotypic resistance. The network is based on Pearson correlation coefficients between the
different determinants. Only correlations with absolute value >0.5 are shown, colour coded as indicated. Strength of correlation is also
coded by proximity of nodes. Genes are shown in green/purple with the green sector indicating the proportion of these genes found in
hospital-acquired isolates. Phenotypic resistance nodes are coloured red.
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However, in these cases, the co-selected genes mediate
resistance to aminoglycosides that are not currently used
to any degree in Scotland (e.g. streptomycin). However,
if, say, an integron mediating trimethoprim resistance
were to acquire a resistance gene to a more commonly
used antibiotic, then this could be strongly selected by tri-
methoprim use.
The CTXM-15 extended spectrum b-lactamase was found
almost exclusively in ST131 isolates of clade C2, but was
present in one isolate ST131 clade A and one isolate of
ST405. This gene is widespread in isolates of ST131 and is
of high clinical significance given that it confers resistance
to the widely used 3rd generation cephalosporins cefotax-
ime and ceftazidime. CTX-M15 has also been reported in
ST405 and other isolates [65]. The CTXM group of genes
originated from chromosomal b-lactamases present in spe-
cies of the microbial genus Kluyvera. The spread within
ST131 occurred during the 1990s and it is now present
worldwide [66], but its presence of this gene in ST405 and
other STs suggests that it has the potential to become even
more widespread.
Outcome of the patients studied here after the isolation of
the infecting E. coli showed no significant dependence on
ST. Patients with HAIs fared worse than those with infec-
tions acquired from the community; the excess mortality
was in the first 90 days after infection suggesting a causal
link. Patients who had a catheter also fared worse in the ini-
tial 90 days. However, it proved difficult to establish from
patients’ notes exactly when catheters were placed. Since
more severely ill patients may be catheterized by preference,
the causal link with catheterization will require further
study. In multivariate analysis, apart from catheterization, a
respiratory source of infection was also a risk factor for
death within 6months. Previous studies have identified
non-urinary source as a risk factor for death [67], and a
comprehensive study in France showed a number of host
factors and portal of entry were more important than bacte-
rial determinants as predictors of death [68]. The associa-
tion with a respiratory source has not previously been
specifically identified.
In conclusion, this study has revealed the complex genetic
patterns present in E. coli isolates from bacteraemic patients
in the West of Scotland in 2013–5. We identify ST69 as an
important contributor to the burden of disease, showing
that it is predominantly a CAI with a distinct genetic make-
up. Using a genome-wide association study, we have identi-
fied genes mediating antibiotic tolerance as important in
HAI and elements of a type VI secretion system in CAI. The
close correlation of resistance to multiple antibiotics that are
largely used in hospitals, show how antibiotic use is driving
selection of such resistance determinants, which subse-
quently can spread to community isolates. It is unlikely
given the diverse mechanisms by which these strains of
E. coli can cause disease that a single intervention will
reduce the incidence of such infections. However, this study
has identified a number of factors that could be targeted to
reduce the burden of this disease.
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